THYROID-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2020-04-10 Jerry6746

你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表:
又投寄了一篇，希望下半年发表出来

117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来

495 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2020-03-20 147d4d04m97暂无昵称

可以投没有约稿的综述吗？

451 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2020-04-10 Jerry6746

你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表:
请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢

南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢

417 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-11-13 追风雨看彩虹

咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表:
中了吗

132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗

414 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

中了吗

416 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-08-27 117qxp

总算发出来了

181 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-08-27 117qxp

又投寄了一篇，希望下半年发表出来

181 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-08-23 117qxp

不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

168 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-08-22 117qxp

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print]

170 0

[GetPortalCommentsPageByObjectIdResponse(id=588617, encodeId=6bd658861e5e, content=你好，支付过程一直error，遇到过没117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, beContent=117qxp 2019-08-27 00:00:00 发表: 又投寄了一篇，希望下半年发表出来, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587048, encodeId=312858e0486b, content=可以投没有约稿的综述吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7dd45247744, createdName=147d4d04m97暂无昵称, createdTime=Fri Mar 20 00:00:00 CST 2020, time=2020-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588615, encodeId=f86e588615b7, content=你好，请问你这个问题解决了么，我现在遇到一样的问题南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, beContent=南瓜。 2020-02-15 00:00:00 发表: 请问这个杂志在投稿的时候需要审稿费，但是支付过程中一直error是怎么回事呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=l6xfT3iazbXeaWL2TgSibJIA&s=100&t=1556395361, createdBy=33b95319198, createdName=Jerry6746, createdTime=Fri Apr 10 00:00:00 CST 2020, time=2020-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579775, encodeId=4d595e977553, content=咋哪哪都有你132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, beContent=132****5832暂无昵称 2019-10-25 00:00:00 发表: 中了吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/11/e1392eb09192c942488a89713fc6b3a5.jpg, createdBy=54792316544, createdName=追风雨看彩虹, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578696, encodeId=66245e8696fa, content=中了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575437, encodeId=7d5c5e543799, content=总算发出来了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575438, encodeId=88975e54384e, content=又投寄了一篇，希望下半年发表出来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Tue Aug 27 00:00:00 CST 2019, time=2019-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575251, encodeId=cf1f5e525185, content=不容易呀，发表出来了RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Fri Aug 23 21:32:00 CST 2019, time=2019-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575183, encodeId=8c325e5183fb, content=RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.Thyroid,Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385. [Epub ahead of print], beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a6949061, createdName=117qxp, createdTime=Thu Aug 22 16:09:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566922, encodeId=6a1456692221, content=后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, beContent=117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/11/b26e34d126ca06961f27cf0d602c5ba5.jpg, createdBy=b5c51935509, createdName=爱科研爱工作, createdTime=Mon Feb 18 00:00:00 CST 2019, time=2019-02-18, status=1, ipAttribution=)]

2019-02-18 爱科研爱工作

后来中了吧？您能分享一下全部的时间表吗？117qxp 2018-08-04 发表::
25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^117qxp 2018-08-04 00:00:00 发表:
25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^

117qxp 2018-08-04 发表:: 25天一审回，意见大修2个reviewers42条建议，3个月回修时间，意见相对比较中肯，细节越来越高，图表修改占了2/3…^_^

156 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务